EUVIMEDObjevte EUVIMED
Video/Audio

Computational Analysis of Plumbagin in Prostate Cancer Using Network Pharmacology and Molecular Dynamics Simulations

Shaofeng Chen, Xiang Fang, Qiguang Liu, Jinyu Zhang, Jingyi Liang, Zhusheng Guo, Huanlin Liang, Dan Li

Journal of Visualized Experiments · 2026

DOI: 10.3791/71843 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Shaofeng Chen and 7 co-authors. Institution: Department of Clinical Laboratory, DongGuan SongShan Lake Tungwah Hospital. Major MEDLINE topics: Naphthoquinones, Prostatic Neoplasms, Molecular Dynamics Simulation, Network Pharmacology.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Prostate cancer is a major contributor to cancer-related mortality among men. Because many patients are diagnosed only after the disease has progressed to a locally advanced or metastatic stage, curative treatment is often no longer possible. In the present study, we applied an integrated computational approach combining network pharmacology, molecular docking, and molecular dynamics simulations to explore the potential molecular mechanisms underlying the therapeutic effects of plumbagin in prostate cancer. Potential therapeutic targets were identified through integrated database analysis, followed by protein-protein interaction network construction, functional enrichment analysis, molecular docking, and molecular dynamics simulations to evaluate the stability of protein-ligand interactions. Our computational analyses identified that plumbagin may form stable interactions with multiple hub targets, including AKT serine/threonine kinase 1 (AKT1), estrogen receptor 1 (ESR1), BCL2 apoptosis regulator (BCL2), epidermal growth factor receptor (EGFR), tumor necrosis factor (TNF), mitogen-activated protein kinase 3 (MAPK3), heat shock protein 90 alpha family class A member 1 (HSP90AA1), SRC proto-oncogene, non-receptor tyrosine kinase (SRC), and peroxisome proliferator activated receptor gamma (PPARG), suggesting its potential to modulate key pathways involved in prostate cancer progression. These in silico findings provide new insights into the possible molecular mechanisms of plumbagin and offer a rationale for future experimental validation. However, further in vitro and in vivo studies are warranted to confirm its functional activity and therapeutic efficacy.

Subjects

MeSH terms (MEDLINE)

NaphthoquinonesProstatic NeoplasmsMolecular Dynamics SimulationNetwork PharmacologyAntineoplastic Agents, PhytogenicMaleHumansProto-Oncogene MasMolecular Docking Simulation

Substances

plumbaginNaphthoquinonesProto-Oncogene MasMAS1 protein, humanAntineoplastic Agents, Phytogenic

Authors and institutions

  • Department of Clinical Laboratory, DongGuan SongShan Lake Tungwah Hospital.
  • Dongguan Key Laboratory of Medical Molecular Biology.
  • Department of Hematology, DongGuan Tungwah Hospital.
  • Department of Emergency, DongGuan Tungwah Hospital.
  • School of Medical Technology, Guangdong Medical University.
  • Department of Clinical Laboratory, DongGuan Tungwah Hospital; gzs_01081@163.com.

Cite

APA

Chen, S., Fang, X., Liu, Q., Zhang, J., Liang, J., Guo, Z., Liang, H., & Li, D. (2026). Computational Analysis of Plumbagin in Prostate Cancer Using Network Pharmacology and Molecular Dynamics Simulations. Journal of Visualized Experiments. https://doi.org/10.3791/71843

Vancouver

Chen S, Fang X, Liu Q, Zhang J, Liang J, Guo Z, et al. Computational Analysis of Plumbagin in Prostate Cancer Using Network Pharmacology and Molecular Dynamics Simulations. Journal of Visualized Experiments. 2026. doi:10.3791/71843

BibTeX
@article{Chen2026,
  author = {Chen, Shaofeng and Fang, Xiang and Liu, Qiguang and Zhang, Jinyu and Liang, Jingyi and Guo, Zhusheng and Liang, Huanlin and Li, Dan},
  title = {Computational Analysis of Plumbagin in Prostate Cancer Using Network Pharmacology and Molecular Dynamics Simulations},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/71843}
}
Start for free →